A recent article by Shashi Kumar, ICGEB New Delhi, in Molecular Plant entitled “Compartmentalized Metabolic Engineering for Artemisinin Biosynthesis and Effective Malaria Treatment by Oral Delivery of Plant Cells" has received worldwide interest. Artemisinin is highly effective against drug-resistant malarial parasites, which affects nearly half of the global population and kills >500 000 people each year. The primary cost of artemisinin is the very expensive process used to extract and purify the drug from Artemisia annua. Elimination of this apparently unnecessary step will make this potent antimalarial drug affordable to the global population living in endemic regions.
From October 24-26 ICGEB hosted the Workshop on the Molecular Biology of Leishmania, at its 8th Edition, in Trieste, Italy. Next week the 2nd ICGEB Workshop on Human Papillomavirus takes place at the Chinese University of Hong Kong.